Statistics for Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
Total visits
| views | |
|---|---|
| Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis | 42 |
Total visits per month
| views | |
|---|---|
| November 2024 | 3 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| González-Duarte2020_Article_AnalysisOfAutonomicOutcomesInA.pdf(legacy) | 37 |
| González-Duarte2020_Article_AnalysisOfAutonomicOutcomesInA.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 11 |
| China | 6 |
| Singapore | 5 |
| Australia | 4 |
| France | 3 |
| United Kingdom | 3 |
| Brazil | 1 |
| Czechia | 1 |
| Italy | 1 |
| Latvia | 1 |
| Mongolia | 1 |
| Portugal | 1 |
| Romania | 1 |
| Russia | 1 |
| Ukraine | 1 |